Activator protein 2α mediates parathyroid TGF-α self-induction in secondary hyperparathyroidism

Journal of the American Society of Nephrology

Volumn 19, Issue 10, 2008, Pages 1919-1928

  Arcidiacono, Maria Vittoria ^a   Cozzolino, Mario ^a   Spiegel, Noah ^a   Tokumoto, Masanori ^a   Yang, Jing ^a   Lu, Yan ^a   Sato, Tetsuhiko ^a   Lomonte, Carlo ^b   Basile, Carlo ^b   Slatopolsky, Eduardo ^a   Dusso, Adriana S ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MIULLI GENERAL HOSPITAL   (Italy)

^c Renal Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2ALPHA; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR AP 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG INHIBITION; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PHOSPHATE INTAKE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SECONDARY HYPERPARATHYROIDISM; UPREGULATION; ANIMAL; CASE CONTROL STUDY; HOSPITALIZATION; HYPERPLASIA; METABOLISM; PARATHYROID GLAND; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UREMIA;

ANIMALS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPLASIA; PARATHYROID GLANDS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TRANSCRIPTION FACTOR AP-2; TRANSFORMING GROWTH FACTOR ALPHA; UREMIA;

EID: 54049097521     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007111216     Document Type: Article

References (35)

1. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
2. Cozzolino M, Dusso AS, Slatopolsky E: Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 12: 2511-2516, 2001
3. Gonzalez EA, Martin KJ: Renal osteodystrophy: Pathogenesis and management. Nephrol Dial Transplant 10[Suppl 3]: 13-21, 1995
4. Parfitt AM: The hyperparathyroidism of chronic renal failure: A disorder of growth. Kidney Int 52: 3-9, 1997
5. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ: Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97: 2534-2540, 1996
6. Silver J, Sela SB, Naveh-Many T: Regulation of parathyroid cell proliferation. Curr Opin Nephrol Hypertens 6: 321-326, 1997
7. Naveh-Many T, Rahamimov R, Livni N, Silver J: Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate, and vitamin D. J Clin Invest 96: 1786-1793, 1995
8. Slatopolsky E, Brown A, Dusso A: Pathogenesis of secondary hyperparathyroidism. Kidney Int Suppl 73: S14-S19, 1999
9. Denda M, Finch J, Slatopolsky E: Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28: 596-602, 1996
10. Gogusev J, Duchambon P, Stoermann-Chopard C, Giovannini M, Sarfati E, Drueke TB: De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism. Nephrol Dial Transplant 11: 2155-2162, 1996
11. Dusso AS, Pavlopoulos T, Naumovich L, Lu Y, Finch J, Brown AJ, Morrissey J, Slatopolsky E: p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 59: 855-865, 2001
12. Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS: p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int 60: 2109-2117, 2001
13. Kumar V, Bustin SA, McKay IA: Transforming growth factor alpha. Cell Biol Int 19: 373-388, 1995
14. Driman DK, Kobrin MS, Kudlow JE, Asa SL: Transforming growth factor-alpha in normal and neoplastic human endocrine tissues. Hum Pathol 23: 1360-1365, 1992
15. Shum L, Reeves SA, Kuo AC, Fromer ES, Derynck R: Association of the transmembrane TGF-alpha precursor with a protein kinase complex. J Cell Biol 125: 903-916, 1994
16. Wong ST, Winchell LF, McCune BK, Earp HS, Teixido J, Massague J, Herman B, Lee DC: The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction. Cell 56: 495-506, 1989
17. Cozzolino M, Lu Y, Sato T, Yang J, Suarez IG, Brancaccio D, Slatopolsky E, Dusso AS: A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Am J Physiol Renal Physiol 289: F1096-F1102, 2005
18. Arcidiacono MV, Sato T, Alvarez-Hernandez D, Yang J, Tokumoto M, Gonzalez-Suarez I, Lu Y, Tominaga Y, Cannata-Andia J, Slatopolsky E, Dusso AS: EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. J Am Soc Nephrol 19: 310-320, 2008
19. Hudson LG, Thompson KL, Xu J, Gill GN: Identification and characterization of a regulated promoter element in the epidermal growth factor receptor gene. Proc Natl Acad Sci U S A 87: 7536-7540, 1990
20. Wang D, Kudlow JE: Purification and characterization of TEF1, a transcription factor that controls the human transforming growth factor-alpha promoter. Biochim Biophys Acta 1449: 50-62, 1999
21. Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD, Barbacci EG, Pustilnik LR, Smolarek TA, Davis JA, Vaidya MP, Arnold LD, Doty JL, Iwata KK, Morin MJ: Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: Dynamics of receptor inhibition in situ and antitumor effects in athymic mice. J Pharmacol Exp Ther 291: 739-748, 1999
22. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712, 1987
23. Cordero JB, Cozzolino M, Lu Y, Vidal M, Slatopolsky E, Stahl PD, Barbieri MA, Dusso A: 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor. J Biol Chem 277: 38965-38971, 2002
24. Cozzolino M, Lu Y, Sato T, Yang J, Suarez IG, Brancaccio D, Slatopolsky E, Dusso AS: A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease. Am J Physiol Renal Physiol 289: F1096-F1102, 2005
25. Lomonte C, Vernaglione L, Chimienti D, Bruno A, Cocola S, Teutonico A, Cazzato F, Basile C: Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism? Clin J Am Soc Nephrol 3: 794-799, 2008
26. Alvarez-Hernandez D, Gonzalez-Suarez I, Naves M, Carrillo-Lopez N, Fdez-Coto T, Fernandez-Martin JL, Cannata-Andia JB: Long-term response of cultured rat parathyroid glands to calcium and calcitriol: The effect of cryopreservation. J Nephrol 18: 141-147, 2005
27. Brown AJ, Zhong M, Ritter C, Brown EM, Slatopolsky E: Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression. Biochem Biophys Res Commun 212: 861-867, 1995
28. Ranson M, Mansoor W, Jayson G: ZD1839 (IRESSA): A selective EGFR-TK inhibitor. Expert Rev Anticancer Ther 2: 161-168, 2002
29. Hinkle CL, Sunnarborg SW, Loiselle D, Parker CE, Stevenson M, Russell WE, Lee DC: Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: The juxtamembrane stalk determines cleavage efficiency. J Biol Chem 279: 24179-24188, 2004
30. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA: An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284, 1998
31. Gunaratnam L, Morley M, Franovic A, de Paulsen N, Mekhail K, Parolin DA, Nakamura E, Lorimer IA, Lee S: Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells. J Biol Chem 278: 44966-44974, 2003
32. Carroll VA, Ashcroft M: Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: Implications for targeting the HIF pathway. Cancer Res 66: 6264-6270, 2006
33. Garcia JA: HIFing the brakes: Therapeutic opportunities for treatment of human malignancies. Sci STKE pe25, 2006
34. Li M, Wang Y, Hung MC, Kannan P: Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer. Int J Cancer 118: 802-811, 2006
35. Nyormoi O, Bar-Eli M: Transcriptional regulation of metastasis-related genes in human melanoma. Clin Exp Metastasis 20: 251-263, 2003